Time-limited cognitive-behavioral therapy and pharmacotherapy of obsessive-compulsive disorder

Crisis Intervention and Time-Limited Treatment

Volumn 5, Issue 1-2, 1999, Pages 37-57

  Franklin, Martin E ^a,b   Foa, Edna B ^b   Kozak, Michael J ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Medical College of Pennsylvania   (United States)

Author keywords

Cognitive behavioral therapy; Exposure treatment; Obsessive compulsive disorder; Pharmacotherapy

Indexed keywords

EID: 0033446897     PISSN: 10645136     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. Amin, M. D., Ban, T. A., Pecknold, J. C., & Klingner, A. (1977). Clomipramine (anafranil) and behavior therapy in obsessive-compulsive and phobic disorders. Journal of International Medical Research, 5, 33-37.
2. AuBuchon, P. G., & Malatesta, V. J. (1994). Obsessive compulsive patients with comorbid personality disorder: Associated problems and response to a comprehensive behavior therapy. Journal of Clinical Psychiatry, 55, 448-453.
3. Baer, L., Jenike, M. A., Black, D. W., Treece, C., Rosenfeld, R., & Greist, J. (1992). Effect of Axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Archives of General Psychiatry, 49(11), 862-866.
4. Beitman, B. D., Beck, N. C., Deuser, W. E., Carter, C. S., Davidson, J. R. T., & Maddock, R. J. (1994). Patient stage of change predicts outcome in a panic disorder medication trial. Anxiety, 1, 64-69.
5. Bisserbe, J. C., Wiseman, R., Rament, M., Goldberg, M., & Lane, R. (1995, May 20-25, 1995). A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder. Paper presented at the 148th Annual Meeting of the American Psychiatric Association, Miami, Florida.
6. Cottraux, J., Mollard, E., Bouvard, M., Marks, I., Sluys, M., Nury, A. M., Douge, R., & Ciadella, P. (1990). A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. International Clinical Psychopharmacology, 5, 17-30.
7. de Araujo, L. A., Ito, L. M., Marks, I. M., & Deale, A. (1995). Does imagined exposure to the consequences of not ritualising enhance live exposure for OCD? A controlled study. I. Main outcome. British Journal of Psychiatry, 167(1), 65-70.
8. DeVeaugh-Geiss, J., Landau, P., & Katz, R. (1989). Treatment of Obsessive Compulsive Disorder with clomipramine. Psychiatric Annals, 19(2), 97-101.
9. DeVeaugh-Geiss, J., Moroz, G., Biederman, J., Cantwell, D., Fontaine, R., Greist, J. H., Reichler, R., Katz, R. & Landau, P. (1992). Clomipramine hydrochloride in childhood and adolescent obsessive compulsive disorder - a multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 31,45-49.
10. Emmelkamp, P. M. G., de Haan, E., & Hoogduin, C. A. L. (1990). Marital adjustment and obsessive-compulsive disorder. British Journal of Psychiatry, 156, 55-60.
11. Emmelkamp, P. M. G., van der Helm, M., van Zanten, B. L., & Plochg, I. (1980). Treatment of obsessive-compulsive patients: The contribution of self-instructional training to the effectiveness of exposure. Behaviour Research and Therapy, 18, 61-66.
12. Emmelkamp, P. M. G., Visser, S., & Hoekstra, R. J. (1988). Cognitive therapy vs. exposure in vivo in the treatment of obsessive-compulsives. Cognitive Therapy and Research, 12, 103-114.
13. Fals-Stewart, W., & Lucente, S. (1993). An MCMI cluster typology of obsessive-compulsives : A measure of personality characteristics and its relationship to treatment participation, compliance and outcome in behavior therapy. Journal of Psychiatric Research, 27(2), 139-154.
14. Fernandez Cordoba, E., & Lopez-Ibor Alino, J. (1967). Monochlorimipramine in mental patients resisting other forms of treatment. Actas Luso-Espanolas de Neurologia y Psiquitria, 26(2), 119-147.
15. Flament, M. F., Koby, E., Rapoport, J. L., Berg, C. J., & et al. (1990). Childhood obsessive-compulsive disorder: A prospective follow-up study. Journal of Child Psychology and Psychiatry and Allied Disciplines, 31(3), 363-380.
16. Flament, M. F., Rapoport, J. L., Berg, C. J., Sceery, W., Kilts, C., & Linnoila, M. (1985). Clomipramine treatment of childhood obsessive-compulsive disorder: A double-blind controlled study. Archives of General Psychiatry, 42(10), 977-983.
17. Flament, M. F., Whitaker, A., Rapoport, J. L., Davies, M., Zaremba, C., Kalikow, K., Sceery, W., & Shaffer, D. (1988). Obsessive compulsive disorder in adolescence: An epidemiological study. Journal of the American Academy of Child and Adolescent Psychiatry, 27(6), 764-771.
18. Foa, E., & Goldstein, A. (1978). Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behavior Therapy, 9, 821-829.
19. Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99, 20-35.
20. Foa, E. B., & Kozak, M. J. (1996). Psychological treatment for obsessive-compulsive disorder. In M. R. Mavissakalian & R. F. Prien (Eds.), Long-Term Treatments of Anxiety Disorders (pp. 285-309). Washington, DC: American Psychiatric Press, Inc.
21. Foa, E. B., Kozak, M. J., Goodman, W. K., Hollander, E., Jenike, M., & Rasmussen, S. (1995). DSM-IV field trial: Obsessive-compulsive disorder. American Journal of Psychiatry, 152, 654.
22. Foa, E. B., Kozak, M. J., Steketee, G. S., & McCarthy, P. R. (1992). Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behavior therapy. British Journal of Clinical Psychology 31, 279-292.
23. Foa, E. B., Steketee, G. S., & Milby, J. B. (1980). Differential effects of exposure and response prevention in obsessive-compulsive washers. Journal of Consulting and Clinical Psychology, 48, 71-79.
24. Foa, E. B., Steketee, G. S., Grayson, J. B., Turner, R. M., & Latimer, P. (1984). Deliberate exposure and blocking of obsessive-compulsive rituals: Immediate and long-term effects. Behavior Therapy, 15, 450-472.
25. Foa, E. B., Steketee, G. S., Turner, R. M., & Fischer, S. C. (1980). Effects of imaginai exposure to feared disasters in obsessive-compulsive checkers. Behaviour Research and Therapy, 18, 449-455.
26. Foa, E. B., & Tillmanns, A. (1980). The treatment of obsessive-compulsive neurosis. In A. Goldstein & E. B. Foa (Eds.), Handbook of Behavioral Interventions: A Clinical Guide (pp. 416-500). New York: Wiley.
27. Fontaine, R., & Chouinard, G. (1986). An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, 6, 98-101.
28. Fontaine, R., & Chouinard, G. (1989). Fluoxetine in the long-term maintenance treatment of obsessive compulsive disorder. Psychiatric Annals, 19(2), 88-91.
29. Freeman, C. P. L., Trimble, M. R., Deakin, J. F. W., Stokes, T. M., & Ashford, J. J. (1994). Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: A multicenter, randomized, double-blind, parallel group comparison. Journal of Clinical Psychiatry, 55(7), 301-305.
30. Franklin, M. E., Kozak, M. J., Cashman, L., Coles, M., Rheingold, A., & Foa, E. B. (1998). Cognitive behavioral treatment of pediatric obsessive compulsive disorder: An open clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 37(4), 412-419.
31. Franklin, M. E., Freshman, M., Stafford, J., Foa, E. B., Davidson, J. R. T., Keefe, F., & Stallings, P. (1996, November). Stage of change assessment in generalized social phobia. Paper presented at the Thirtieth Annual Convention of the Association for the Advancement of Behavior Therapy, New York, NY.
32. Goodman, W. K., Price, L. H., & Charney, D. S. (1989). Fluvoxamine in Obsessive Compulsive Disorder. Psychiatric Annals, 19(2), 92-96.
33. Goodman, W. K., Price, L. H., Rasmussen, S. A., Delgado, P. L., & et al. (1989). Efficacy of fluvoxamine in obsessive-compulsive disorder: A double-blind comparison with placebo. Archives of General Psychiatry, 46(1), 36-44.
34. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., & Charney, D. S. (1989a). The Yale-Brown Obsessive Compulsive Scale: II. Validity. Archives of General Psychiatry, 46(11), 1012-1016.
35. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., Heninger, G. R., & Charney, D. S. (1989b). The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry, 46(11), 1006-1011.
36. Greist, J. H. (1992). An integrated approach to treatment of obsessive compulsive disorder 144th Annual Meeting of the American Psychiatric Association: Obsessive compulsive disorder: Integrating theory and practice (1991, New Orleans, Louisiana). Journal of Clinical Psychiatry, 53(4, Suppl), 38-41.
37. Greist, J., Chouinard, G., DuBoff, E., Halaris, A., Kim, S. W., Koran, L., Liebowitz, M., Lydiard, R. B., Rasmussen, S., White, K., & Sikes, C. (1995). Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Archives of General Psychiatry, 52,289-295.
38. Greist, J. H., Jefferson, J. W., Kobak, K. A., Katzelnick, D. J., & Serlin, R. C. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Archives of General Psychiatry 52(1), 53-60.
39. Hembree, E. A., Cohen, A., Riggs, D., Kozak, M. J., & Foa, E. B. (1992). The long-term efficacy of behavior therapy and serotonergic medications in the treatment of obsessive-compulsive ritualizers. Unpublished manuscript.
40. Hiss, H., Foa, E. B., & Kozak, M. J. (1994). Relapse prevention program for treatment of obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology, 62(4), 801-808.
41. Hollander, E. (1989). Body dysmorphic disorder and its relationship to obsessive-compulsive disorder. Unpublished manuscript.
42. Hudson, J. I., Pope, H. G., Yurgelun-Todd, D., Jonas, J. M., & Frankenburg, F. R. (1987). A controlled study of lifetime prevalence of affective and other psychiatric disorder in bulimic outpatients. American Journal of Psychiatry, 144, 1283-1287.
43. Insel, T. R., & Akiskal, H. S. (1986). Obsessive-compulsive disorder with psychotic features: A phenomenologic analysis. American Journal of Psychiatry, 143(12), 1527-1533.
44. Jenike, M. A., Baer, L., & Carey, R. J. (1986). Coexistent obsessive-compulsive disorder and schizotypal personality disorder: A poor prognostic indicator. Archives of General Psychiatry, 43(3), 296.
45. Jenike, M. A., Buttolph, L., Baer, L., Ricciardi, J., & Holland, A. (1989). Open trial of fluoxetine in obsessive-compulsive disorder. American Journal of Psychiatry, 146(7), 909-911.
46. Karno, M., Golding, J. M., Sorenson, S. B., & Burnam, M. A. (1988). The epidemiology of obsessive-compulsive disorder in five US communities. Archives of General Psychiatry, 45(12), 1094-1099.
47. Kasvikis, Y. G., Tsakiris, F., Marks, I. M., Basoglu, M., & Noshirvani, H. F. (1986). Past history of anorexia nervosa in women with obsessive-compulsive disorder. International Journal of Eating Disorders, 5(6), 1069-1075.
48. Kozak, M. J., & Foa, E. B. (1994). Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behaviour Research and Therapy, 32(3), 343-353.
49. Kozak, M. J., Liebowitz, M. R., & Foa, E. B. (in press). Cognitive behavior therapy and pharmacotherapy for OCD: The NIMH-Sponsored Collaborative Study. In W. Goodman, M. Rudorfer, & J. Maser (Eds.), Obsessive Compulsive Disorder: Contemporary Issues in Treatment.
50. Laessle, R. G., Kittl, S., Fichter, M. M., et al. (1987). Major affective disorder in anorexia nervosa and bulimia: A descriptive diagnostic study. British Journal of Psychiatry, 151, 785-789.
51. Leckman, J. F., & Chittenden, E. H. (1990). Gilles de La Tourette's syndrome and some forms of obsessive-compulsive disorder may share a common genetic diathesis. Encephale, 16(Spec No 1), 321-323.
52. Lelliott, P. T., Noshirvani, H. F., Basoglu, M., Marks, I. M., & Monteiro, W. O. (1988). Obsessive-compulsive beliefs and treatment outcome. Psychological Medicine, 18, 697-702.
53. Leonard, H. L., Swedo, S. E., Lenane, M. C., Rettew, D. C., Cheslow, D. L., Hamburger, S. D. & Rapoport, J. L.. (1991). A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry, 48(10), 922-927.
54. Liebowitz, M. R., Hollander, E., Schneier, F., Campeas, R., Hatterer, J., Papp, L., Fairbanks, J., Sandberg, D., Davies, S., & Stein, M. (1989). Fluoxetine treatment of obsessive-compulsive disorder: An open clinical trial. Journal of Clinical Psychopharmacology, 9(6), 423-427.
55. March, J. S., Leonard, H. L., & Swedo, S. E. (1995). Obsessive-compulsive disorder. In J. S. March (Ed.) Anxiety Disorders in Children and Adolescents. New York: Guilford Press.
56. March, J. S. (1995). Cognitive-behavioral psychotherapy for children and adolescents with OCD: A review and recommendations for treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 34(1), 7-18.
57. March, J. S., & Mulle, L. (1993). "How OCD Off My Land": A Cognitive-Behavioral Program for the Treatment of Obsessive-Compulsive Disorder in Children and Adolescents. Unpublished manuscript.
58. March, J. S., Mulle, K., & Herbel, B. (1994). Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: An open trial of a new protocol-driven treatment package. Journal of the American Academy of Child and Adolescent Psychiatry, 33(3), 333-341.
59. Marks, I. M., Lelliott, P. T., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., & Kasvikis, Y. (1988). Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. British Journal of Psychiatry, 152, 522-534.
60. Marks, I. M., Stern, R. S., Mawson, D., Cobb, J., & McDonald, R. (1980). Clomipramine and exposure for obsessive-compulsive rituals -I. British Journal of Psychiatry, 136, 1-25.
61. Mattes, J. A. (1994). Fluvoxamine in obsessive-compulsive non-responders to clomipramine or fluoxetine (letter). American Journal of Psychiatry, 151(10), 1524.
62. Meyer, V. (1966). Modification of expectations in cases with obsessional rituals. Behaviour Research and Therapy., 4, 273-280.
63. Meyer, V., & Levy, R. (1973). Modification of behavior in obsessive-compulsive disorders. In H. E. Adams & P. Unikel (Eds.), Issues and trends in behavior therapy (pp. 77-136). Springfield, IL: Charles C. Thomas.
64. Meyer, V., Levy, R., & Schnurer, A. (1974). The behavioural treatment of obsessive-compulsive disorders. In H. R. Beech (Ed.), Obsessional States (pp. 233-258). London: Methuen.
65. Minichiello, W. E., Baer, L., & Jenike, M. A. (1987). Schizotypal Personality Disorder: A poor prognostic indicator for behavior therapy in the treatment of Obsessive-Compulsive Disorder. Journal of Anxiety Disorders, 1(3), 273-276.
66. Montgomery, S. A., McIntyre, A:, Osterheider, M., Sarteschi, R, Zitterl, W., Zohar, J., Birkett, M., Wood, A. J., & The Lilly Europen OCD Study Group. (1993). A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder European Neuropsychopharmacology, 3(2), 143-152.
67. Myers, J., Weissman, M., Tischler, G., Holzer, C., Leaf, P., Orvaschel, H., Anthony, J., Boyd, J., Burke, J., Kramer, M., & Stoltzman, R. (1984). Six-month prevalence of psychiatric disorders in three communities: 1980-1982. Archives of General Psychiatry, 41, 959-967.
68. Neziroglu, F. (1979). A combined behavioral-pharmacotherapy approach to obsessive-compulsive disorder. In J. Oriols, C. Ballus, M. Gonzalez, & J. Prijol (Eds.), Biological Psychiatry Today. Amsterdam: Elsivier/North Holland Press.
69. O'Sullivan, G., Noshirvani, H., Marks, I., Monteiro, W., & Lelliott, P. (1991). Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. Journal of Clinical Psychiatry, 52(4), 150-155.
70. Pato, M. T., Zohar-Kadouch, R., Zohar, J., & Murphy, D. L. (1988). Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. American Journal of Psychiatry, 145(12), 1521-1525.
71. Pauls, D. L., Towbin, K. E., Leckman, J. F., Zahner, G. E., & et al. (1986). Gilles de la Tourette's syndrome and obsessive-compulsive disorder: Evidence supporting a genetic relationship. Archives of General Psychiatry, 43(12), 1180-1182.
72. Perse, T. L., Greist, J. H., Jefferson, J. W., Rosenfeld, R., & Dar, R. (1987). Fluvoxamine treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 144(12), 1543-1548.
73. Pfohl, B., Black, D. W., Noyes, R., Coryell, W. H., & Barrash, J. (1991). Axis I and Axis II comorbidity findings: Implications for validity. In J. M. Oldham (Ed.), Personality Disorders: New Perspectives on Diagnostic Validity. Progress in psychiatry, No. 20 (pp. 147-161). Washington, DC: American Psychiatric Press, Inc.
74. Pigott, T. A., Pato, M. T., Bernstein, S. E., Grover, G. N., Hill, J. L., Tolliver, T., & Murphy, D. L. (1990). Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: Behavioral and biological results. Archives of General Psychiatry, 47(10), 926-932.
75. Price, L. H., Goodman, W. K., Charney, D. S., Rasmussen, S. A., & Heninger, G. R. (1987). Treatment of severe obsessive-compulsive disorder with fluvoxamine. American Journal of Psychiatry, 144(8), 1059-1061.
76. Prochaska, J. O., & DiClemente, C. C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51, 390-395.
77. Rasmussen, S. A., & Eisen, J. L. (1989). Clinical features and phenomenology of Obsessive Compulsive Disorder. Psychiatric Annals, 19(2), 67-73.
78. Rasmussen, S. A., & Eisen, J. L. (1990). Epidemiology of obsessive compulsive disorder. Journal of Clinical Psychiatry, 51(2, Suppl), 10-13.
79. Rasmussen, S. A., Goodman, W. K., Greist, J. J., Jenike, M. A., Kozak, M. J., Liebowitz, M. R., Robinson, D. G., & White, K. L. (submitted). Fluvoxamine in the treatment of obsessive-compulsive disorder: A multi-center double-blind placebo-controlled study in outpatients. American Journal of Psychiatry.
80. Rasmussen, S. A., & Tsuang, M. T. (1986). Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. American Journal of Psychiatry, 143(3), 317-322.
81. Riddle, M. A., Scahill, L., King, R. A., Hardin, M. T., & et al. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31(6), 1062-1069.
82. Riggs, D. S., Hiss, H., & Foa, E. B. (1992). Marital distress and the treatment of obsessive compulsive disorder. Behavior Therapy, 23(4), 585-597.
83. Robins, L. N., Helzer, J. E., Weissman, M. M., & Orvaschel, H. (1984). Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry, 41, 949-958.
84. Smeraldi, E., Erzegovesi, S., Bianchi, I., Pasquali, L., Cocchi, S., & Ronchi, P. (1992). Fluvoxamine vs. clomipramine treatment in obsessive-compulsive disorder: A preliminary study. New Trends in Experimental and Clinical Psychiatry, 2, 63-65.
85. Steketee, G. S., Foa, E. B., & Grayson, J. B. (1982). Recent advances in the treatment of obsessive-compulsives. Archives of General Psychiatry, 39, 1365-1371.
86. Swedo, S. E., Rapoport, J. L., Leonard, H. L., Lenane, M., & Cheslow, D. (1989). Obsessive-compulsive disorder in children and adolescents: Clinical phenomenology of 70 consecutive cases. Archives of General Psychiatry, 46(4), 335-341.
87. Tamimi, R. R., Mavissakalian, M. R., Jones, B., & Olson, S. (1991). Clomipramine versus fluvoxamine in obsessive-compulsive disorder. Annals of Clinical Psychiatry, 3, 275-279.
88. Thoren, P., Asberg, M., Chronholm, B., Jornestedt, L., & Traskman, L. (1980). Clomipramine treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 37, 1281-1285.
89. Tollefson, G. D., Rampey, A. H., Potvin, J. H., Jenike, M. A., Rush, A. J., Domingues, R. A., Koran, L. M., Shear, M. K., Goodman, W., & Genduso, L. A. (1994). A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 51(7), 559-567.
90. Tynes, L. L., White, K., & Steketee, G. S. (1990). Toward a new nosology of obsessive compulsive disorder. Comprehensive Psychiatry, 31(5), 465-480.
91. Valleni-Basile, L. A., Garrison, C. Z., Jackson, K. L., Waller, J. L., McKeown, R. E., Addy, C. L., & Cuffe, S. P. (1994). Frequency of obsessive-compulsive disorder in a community sample of young adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 33(6), 782-791.
92. Van Oppen, P., de Haan, E., Van Balkom, A. J. L. M., Spinhoven, P., Hoogduin, K., & van Dyck, R. (1995). Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behaviour Research and Therapy, 33(4), 379-390.
93. Zohar, J., Judge, R., & OCD Paroxetine Study Investigators. (1996). Paroxetine versus Clomipramine in the treatment of obsessive-compulsive disorder. British Journal of Psychiatry, 169, 468-474.